
2018 PhD, Queensland University of Technology, Australia 2014 M.Sci. Dalian University of Technology, China 2011 B.Eng. Southwest Jiaotong University, China
In 2018, Ming joined CARP to work on in-silico hit screening for the development of anti-cancer and anti-ageing drugs targeting different proteins such as FKBP52 and BANF1. Ming is proficient in computational technics such as molecular docking, molecular dynamics, in-silico hit screening and the design of small molecules. With these technics, Ming is interested in developing anti-cancer and anti-ageing drugs and exploring the molecular mechanisms of biological signalling pathways regulating various diseases.